Investing For Value

Value Investing Case Study 125-1: A fundamental analysis of Time Dotcom Berhad to assess whether it is an investment opportunity or a value trap?   Most investors think of TIME dotCom Berhad as just another telecom company. That is a mistake.  Over the past decade, TIME has quietly transformed itself into a data infrastructure platform. And the numbers tell an interesting story. Revenue grew at close to 10% annually, driven not by price hikes or flashy new products, but by something far more powerful — exploding data demand. As more businesses and consumers rely on digital services, TIME benefits from a simple but effective model: more data flowing through its network. Even more interesting is what happened after 2023. Following a major restructuring, the business became more capital-efficient and asset-light, improving how effectively it uses its network. At the same time, its high fixed-cost structure means that every extra ringgit of revenue can disproportion...

Tips E-34: A 1-minute summary of my fundamental analysis of nLight (NASDAQ: LASR)  Investment Thesis nLIGHT shows early signs of improvement, but remains sub-scale and unprofitable. The 2025 uptick in revenue and margins is encouraging, yet the company operates far below breakeven and trails peers significantly.  Main Business nLIGHT designs and manufactures high-power lasers for industrial, microfabrication, and defense applications across global markets. The company remains heavily US-centric and lacks scale relative to competitors. Growth Revenue grew at an 8.8% CAGR over the past decade, below industry growth rates, with declines from 2022 to 2024. While 2025 shows a recovery with mid-teens growth guidance, sustained acceleration is required to approach breakeven scale. Profitability With breakeven estimated at  USD 384 million versus a USD 217 million run rate, nLIGHT is far from profitability. Margins and fixed cost control have historically deteriorat...

This is Chapter 10 of my book Mastering Value Investing: Practical Strategies for Real-World Results . Go there for links to the other chapters.   The real analytical edge does not come from collecting more information - it comes from connecting the right dots. In this Chapter, I break down how professional investors move from scattered facts to real conviction. Because every company throws off fragments — revenue trends, margins, and management narratives. On their own, they are meaningless. But when you connect them properly, a very different picture emerges. Take a real-world case: a global fertilizer company that grew revenue. The company expanded internationally. Sounds impressive, right? But when you connect the dots, a different story appears. Growth was driven more by pricing than real demand. Profits did not follow revenue. Returns deteriorated. And the one “great” year? It was driven by a temporary external shock - not a stronger business. This is where most...

Tips E-33: A 1-minute summary of my fundamental analysis of Keysight Technologies Inc. (NYSE: KEYS) Investment Thesis Keysight is a high-quality industry leader with strong moats. The company combines steady revenue growth, strong cash generation, and sector-leading returns, yet margins and capital efficiency have remained largely flat over time. At current prices, the stock reflects improvements not yet demonstrated. Main Business Keysight provides electronic test and measurement solutions supporting communications, semiconductors, and industrial applications across global markets. It serves evolving technologies such as 5G, AI, and EVs. While capabilities have expanded through acquisitions and software integration, the company’s core product-market mix has remained relatively stable over the past decade. Growth Keysight delivers steady mid-single-digit growth, driven primarily by organic expansion supported by resilient end-market demand. Profitability PAT grew only 2.0% CAGR ov...

Value Investing Case Study 124-1: A fundamental analysis of KPJ Healthcare Berhad to assess whether it is an investment opportunity.     KPJ Healthcare looks like a textbook “defensive winner.” Profits are rising, returns are improving, and it operates in a sector backed by powerful long-term trends. But dig a little deeper, and the story becomes far more interesting. Over the past decade, KPJ has quietly transformed itself. It has shifted from a capital-heavy hospital builder into a more asset-light operator focused on efficiency and patient volume. On the surface, this strategy is working - profits have grown faster than revenue and margins have expanded. So, is this a turnaround success? Not so fast. A big part of the recent improvement came after COVID, when patient volumes rebounded sharply. At the same time, KPJ changed how it structures its assets - moving towards leasing rather than owning hospitals. This has the effect of making returns look bet...